Seroatlas · Human Serome Atlas

CYBB

NADPH oxidase 2

Also known as: CGD, CY24B_HUMAN, GP91-PHOX, NOX2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P04839
Gene
CYBB
Ensembl
ENSG00000165168
Chromosome
X
Canonical length
570 aa
Protein class
Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters

OverviewNCBI Gene

Cytochrome b (-245) is composed of cytochrome b alpha (CYBA) and beta (CYBB) chain. It has been proposed as a primary component of the microbicidal oxidase system of phagocytes. CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease (CGD). In this disorder, there is decreased activity of phagocyte NADPH oxidase; neutrophils are able to phagocytize bacteria but cannot kill them in the phagocytic vacuoles. The cause of the killing defect is an inability to increase the cell's respiration and consequent failure to deliver activated oxygen into the phagocytic vacuole. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

570 residues, UniProt reviewed canonical sequence.

>P04839|CYBB
     1  MGNWAVNEGL SIFVILVWLG LNVFLFVWYY RVYDIPPKFF YTRKLLGSAL ALARAPAACL
    61  NFNCMLILLP VCRNLLSFLR GSSACCSTRV RRQLDRNLTF HKMVAWMIAL HSAIHTIAHL
   121  FNVEWCVNAR VNNSDPYSVA LSELGDRQNE SYLNFARKRI KNPEGGLYLA VTLLAGITGV
   181  VITLCLILII TSSTKTIRRS YFEVFWYTHH LFVIFFIGLA IHGAERIVRG QTAESLAVHN
   241  ITVCEQKISE WGKIKECPIP QFAGNPPMTW KWIVGPMFLY LCERLVRFWR SQQKVVITKV
   301  VTHPFKTIEL QMKKKGFKME VGQYIFVKCP KVSKLEWHPF TLTSAPEEDF FSIHIRIVGD
   361  WTEGLFNACG CDKQEFQDAW KLPKIAVDGP FGTASEDVFS YEVVMLVGAG IGVTPFASIL
   421  KSVWYKYCNN ATNLKLKKIY FYWLCRDTHA FEWFADLLQL LESQMQERNN AGFLSYNIYL
   481  TGWDESQANH FAVHHDEEKD VITGLKQKTL YGRPNWDNEF KTIASQHPNT RIGVFLCGPE
   541  ALAETLSKQS ISNSESGPRG VHFIFNKENF

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CYBB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
6
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
150 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 150 nTPM
  • appendix: 141 nTPM
  • lymph node: 86 nTPM
  • lung: 84 nTPM
  • spleen: 79 nTPM
  • tonsil: 65 nTPM

Single-cell type

  • neutrophil progenitors: 1,958 nCPM
  • monocytes: 776 nCPM
  • kupffer cells: 613 nCPM
  • macrophages: 418 nCPM
  • microglia: 358 nCPM
  • neutrophils: 352 nCPM

Immune cell

  • classical monocyte: 319 nTPM
  • intermediate monocyte: 241 nTPM
  • non-classical monocyte: 227 nTPM
  • total PBMC: 200 nTPM
  • eosinophil: 106 nTPM
  • plasmacytoid DC: 80 nTPM

Brain region

  • white matter: 57 nTPM
  • medulla oblongata: 34 nTPM
  • spinal cord: 27 nTPM
  • thalamus: 25 nTPM
  • choroid plexus: 25 nTPM
  • pons: 24 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CYBB.

Disease | AllUniProt

Conditions CYBB is implicated in, by any mechanism.

Disease | GeneticClinVar

209 pathogenic / likely-pathogenic of 906 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.19
gnomAD pLI
1
gnomAD missense Z
2.19
DepMap mean gene effect
0.12
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CYBB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CYBB as an antibody target. Whether an autoantibody or antibody against CYBB could matter depends on whether native CYBB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CYBB is annotated at the cell surface, where native CYBB is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label CYBB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CYBB. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...